Geneva, Feb. 13 -- International Clinical Trials Registry received information related to the study (ISRCTN15332421) titled 'The influence of a prehabilitation on the health of lung cancer patients' on Feb. 5.
Study Type: Interventional
Study Design:
Allocation: Randomized controlled trial
Masking: Open (masking not used)
Control: Active
Assignment: Parallel
Purpose: Prevention, Supportive care, Treatment
Primary Sponsor: Poznan University of Medical Sciences
Condition:
Lung cancer
Cancer
Intervention:
Arm 1: Interventional Group (Multimodal Prehabilitation)
Participants in this arm receive a comprehensive, supervised multimodal prehabilitation program lasting for a total duration of 2-4 weeks prior to surgery.
The interventio...